Anastrozole Tablet, Film Coated
Product Images NDC 72789-575

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 72789-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789575)

Anastrozole Tablets USP 1 mg film-coated tablets, packaged in a carton containing 15 tablets. The label shows the product is marketed and packaged by PD-Rx Pharmaceuticals, Inc. in Oklahoma City, OK and manufactured by Eugia Pharma Specialities Limited in India. The label includes storage information and a barcode.*

FDA Label Image

Anastrozole-fig1 (Anastrozole Fig1)

A line graph comparing disease-free survival in months between anastrozole and tamoxifen treatments. The x-axis represents disease-free survival time in months, while the y-axis shows the proportion alive and disease-free. Two lines indicate outcomes for randomized treatment groups: anastrozole (dashed line) and tamoxifen (solid line) with patient risk numbers listed below.*

FDA Label Image

Anastrozole-fig2 (Anastrozole Fig2)

A line graph depicting disease-free survival over time in months for patients randomized to Anastrozole or Tamoxifen treatment. The y-axis shows the proportion alive and disease-free, and the x-axis represents disease-free survival in months up to 84 months. The chart includes a numerical summary of patient counts at various time points for both treatments.*

FDA Label Image

Anastrozole-fig3 (Anastrozole Fig3)

A Kaplan-Meier curve chart showing the proportion of event-free patients over time in months, comparing Anastrozole and Tamoxifen treatments. The x-axis represents time to event in months (0 to 120), and the y-axis shows the proportion event-free (0.50 to 1.00). The chart includes a table of the number of patients at risk at multiple time points for both treatments.*

FDA Label Image

Anastrozole-fig4 (Anastrozole Fig4)

A Kaplan-Meier curve showing the proportion of patients event-free over time (in months) comparing randomized treatment with Anastrozole versus Tamoxifen. The solid line represents Anastrozole and the dashed line represents Tamoxifen. Below the graph, the number of patients at risk at various time points is listed for each treatment group.*

FDA Label Image

Anastrozole-fig5 (Anastrozole Fig5)

A Kaplan-Meier survival curve chart comparing the proportion of patients not experiencing disease progression over time (in months) between Anastrozole and Tamoxifen treatment groups. The x-axis represents time to progression in months, and the y-axis shows the proportion not progressing. Patient risk counts are noted below the x-axis at various time points.*

FDA Label Image

Anastrozole-fig6 (Anastrozole Fig6)

A Kaplan-Meier survival curve showing the proportion of patients not progressing over time up to 40 months. The graph compares two randomized treatments: Anastrozole (solid line) and Tamoxifen (dashed line), with time to progression in months on the x-axis and proportion not progressing on the y-axis. The number of patients at risk at various time points is displayed below the x-axis.*

FDA Label Image

Chemical Structure (Anastrozole Str)

Chemical structure diagram of the active ingredient anastrozole. The structure shows a benzene ring substituted with two cyanide and two methyl groups, and a triazole ring connected via a methylene bridge.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.